A central platform for healthcare professionals interested in contemporary biomarker diagnostics in cardiometabolic diseases. Register here to learn more about CarDiaLogue
This platform is the one-stop content site for healthcare professionals passionate about cardiometabolic disease management. World-renown experts and thought leaders share the latest clinical evidence, present the newest guidelines and offer educational events, providing actionable insights for the management of cardiometabolic diseases.
Latest CarDiaLogue articles
A manifesto led by the international alliance Global Heart Hub calls for a collective commitment to tangible actions towards CVD prevention and diagnosis.
In this insightful interview, Dr. Vaduganathan highlights the value of biomarkers like NT-proBNP for the diagnosis of HFpEF.
Content hub dedicated for c-suite professionals/executive leaders and other decision makers in healthcare, specifically diagnostics. Platform which inspires our readers to solve healthcare transformation challenges in a new way.
Scientific educational portal for healthcare professionals passionate about cardiovascular disease management. Aiming to provide new horizons of diagnostics and digital advancements to partner physicians in improving patient outcomes in the Asia and the Pacific region.
Our promise is to empower laboratories and the people within them. We do this by providing clinical and strategic insights, support, and solutions from the industry’s top innovators.
Join the #CarDiaLogue today and sign up for updates.
CarDiaLogue brings you the latest insights and valuable perspectives from some of the sharpest minds in cardiology to complement your specialist skills.
